Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.34 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20996961 | 1.00 | PSENEN (0.34) | PSENENCTSSCTSKDPP4 | |
| SCHEMBL22692391 | 0.83 | PSENEN (0.34) | PSENENCTSSCTSK | |
| SCHEMBL18811839 | 0.83 | PSENEN (0.36) | PSENENCTSSCTSK | |
| SCHEMBL23682495 | 0.83 | PSENEN (0.36) | PSENENCTSSCTSK | |
| SCHEMBL18812406 | 0.83 | PSENEN (0.34) | PSENENCTSSCTSK | |
| SCHEMBL22139575 | 0.80 | PSENEN (0.38) | PSENENCTSSCTSK | |
| SCHEMBL24015645 | 0.80 | PSENEN (0.33) | PSENEN | |
| SCHEMBL24454098 | 0.80 | PSENEN (0.33) | PSENEN | |
| SCHEMBL13759903 | 0.79 | DPP4 (0.32) | DPP4 | |
| SCHEMBL17664752 | 0.79 | DPP4 (0.32) | DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11529422-B2 | Polymer linkers and their uses | NOVACYTE THERAPEUTICS COMPANY., LTD (CN) | 2022-12-20 | — | — | US | disclosed |
| US-20200155693-A1 | POLYMER LINKERS AND THEIR USES | NOVACYTE, INC. (US) | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11529422-B2 | Polymer linkers and their uses | PHF2, PHF8, PAICS | PSENEN 2225/4885CTSS 3881/4885CTSK 4134/4885 |
| US-20200155693-A1 | POLYMER LINKERS AND THEIR USES | PHF2, PHF8, PAICS | PSENEN 2225/4885CTSS 3881/4885CTSK 4134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.